APA aipamena

Fathi, A. T., DiNardo, C. D., Kline, I., Kenvin, L., Gupta, I., Attar, E. C., . . . de Botton, S. (2018). Differentiation Syndrome Associated With Enasidenib, a Selective Inhibitor of Mutant Isocitrate Dehydrogenase 2: Analysis of a Phase 1/2 Study. JAMA Oncol.

Chicago Style aipamena

Fathi, Amir T., Courtney D. DiNardo, Irina Kline, Laurie Kenvin, Ira Gupta, Eyal C. Attar, Eytan M. Stein, and Stephane de Botton. "Differentiation Syndrome Associated With Enasidenib, a Selective Inhibitor of Mutant Isocitrate Dehydrogenase 2: Analysis of a Phase 1/2 Study." JAMA Oncol 2018.

MLA aipamena

Fathi, Amir T., et al. "Differentiation Syndrome Associated With Enasidenib, a Selective Inhibitor of Mutant Isocitrate Dehydrogenase 2: Analysis of a Phase 1/2 Study." JAMA Oncol 2018.